January 9, 2013

Procter & Gamble has announced that current P&G director Johnathan Rodgers has decided not to seek re-election at P&G’s annual shareholder meeting in October 2013, choosing to retire from the board at that time.

January 7, 2013

A company that provides cloud-based electronic health record, practice management and care-coordination services is buying a developer of point-of-care mobile health applications for physicians.

January 4, 2013

Hormel Foods announced it has entered into a definitive agreement to acquire the Skippy peanut butter business from Unilever United States, of Englewood Cliffs, N.J.

December 28, 2012

Watson Pharmaceuticals on Friday confirmed that Actavis, which was acquired by Watson in October, has filed an abbreviated new drug applications with the Food and Drug Administration seeking approval to market bortezomib, a generic version of Millennium Pharmaceuticals' Velcade.

December 20, 2012

Actavis has donated $200,000 worth of medicines to help people affected by Hurricane Sandy, a charity organization said Thursday.

December 18, 2012

Drug maker Merz Pharmaceuticals is suing Par Pharmaceutical over the latter's attempt to market a generic drug for cerebral palsy patients, according to published reports.

December 18, 2012

The Vitamin Shoppe will buy a Pacific Northwest-based supplement chain, the New Jersey-based company said.

December 18, 2012

PepsiCo's Tropicana brand is introducing a new way for moms to sneak veggies into their kids' diets: Farmstand, a fruit-and-vegetable drink to hit the refrigerated section of supermarkets in January.

December 17, 2012

Japanese drug maker Takeda Pharmaceutical Co. is selling its generics business to India-based Sun Pharmaceutical Industries, Takeda said.

December 11, 2012

Biotech and vaccines company Nuron Biotech has bought rights from Pfizer for a vaccine to prevent infection by a bacteria that is a major cause of infectious disease around the world.

December 10, 2012

The Jean Coutu Group recently announced that it is acquiring a 50% stake in Le Groupe Médicus, which specializes in orthotic and prosthetic devices.

December 7, 2012

CVS Caremark is reportedly looking to expand outside of the United States by acquiring Onofre, the eighth-largest pharmacy chain in Brazil, according to published reports.

December 5, 2012

Walgreens last month acquired UCH Pharmaceutical Services, an independent retail pharmacy based in Indiana, the company that helped broker the deal announced Wednesday.

December 3, 2012

Dean Foods has entered into a definitive agreement to sell its Morningstar Foods division to Saputo for $1.45 billion.

November 29, 2012

It’s a marriage of industry icons. In June, Walgreens finally made a long-awaited leap across the Atlantic to acquire British-based Alliance Boots, one of the world’s premier retailers of pharmaceuticals, health and beauty aids, and beauty care products. 


November 29, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

November 29, 2012

Not Your Mother’s hair care is further expanding its distribution by adding Ricky’s NYC to its retail mix.


November 28, 2012

L&R Distributors on Wednesday acquired the assets of SAJ Distributors, along with the private-label line Select Brand, from Walgreens.

November 26, 2012

Brynwood Partners VI on Monday announced that it has sold its Balance Bar Company, which manufactures nutrition and energy bars, to NBTY.

November 19, 2012

The year 2012 is coming to an end, and it's been a big year for generic drugs. It's the year that the most lucrative drug of all time became commoditized. It's the year that Watson bought Actavis for $5.6 billion. And it's the year the FDA released draft guidance for biosimilars regulations. All of these events speak to some of the most important trends in the world of generics — trends that are often interrelated.

November 19, 2012

DSN profiled six companies that sell on their American-made heritage as part of its "Made in America" report.

November 16, 2012

The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.

November 15, 2012

Initial shipment of a generic appetite suppressant has started, the drug's manufacturer said Thursday.

November 14, 2012

Consumer products company Spectrum Brands Holdings has acquired a 56% interest in Shaser Bioscience, a privately held developer of energy-based, aesthetic dermatological technology for home use devices, for $50 million in cash.